Brief: Ikena Oncology Announces Stockholder Approval Of Merger With Inmagene Biopharmaceuticals
15/07/2025 21:48
July 15 (Reuters) - Ikena Oncology Inc IKNA.O: IKENA ONCOLOGY ANNOUNCES STOCKHOLDER APPROVAL OF MERGER WITH INMAGENE BIOPHARMACEUTICALS IKENA ONCOLOGY INC - ANNOUNCES 1-FOR-12 REVERSE STOCK SPLIT IKENA ONCOLOGY INC - COMBINED COMPANY TO TRADE ON NASDAQ AS 'IMA' Source text: ID:nGNX6rrbtj Further company coverage: IKNA.O
Recent news on ImageneBio
See all newsU.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma
Brief: ImageneBio Inc - On Oct 23, Elects Not To Renew Agreement With Miragene - SEC Filing
ImageneBio Inc expected to post a loss of $1.56 a share - Earnings Preview
Brief: Ikena Oncology Announces Stockholder Approval Of Merger With Inmagene Biopharmaceuticals